🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
40Score
DipBuster Score™
$184.93
$1.715 (-0.92%)
Live price · Source: Yahoo
52-Week Position
$160.93
29% of range
$242.80
Beta
0.841
Market-like
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.841
52W High$242.80
52W Low$160.93
🤖
Watch — Score 40/100
Zone: Buy Zone
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position29% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.841
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Danaher Corporation free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
28/25
Momentum & Volume
7/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟡
Watch
DipBuster Score: 40/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Envir…
Sector
Healthcare
Market
🇺🇸 US
CEO
Rainer Blair
Staff
61,000 employees
Website